{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T03:48:33Z","timestamp":1773632913778,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T00:00:00Z","timestamp":1559692800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T00:00:00Z","timestamp":1559692800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003443","name":"Ministry of Education and Science of the Russian Federation","doi-asserted-by":"crossref","award":["6.9906.2017\/BCh"],"award-info":[{"award-number":["6.9906.2017\/BCh"]}],"id":[{"id":"10.13039\/501100003443","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Toxicol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s12012-019-09532-x","type":"journal-article","created":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T03:03:00Z","timestamp":1559703780000},"page":"518-528","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["The Use of iPSC-Derived Cardiomyocytes and Optical Mapping for Erythromycin Arrhythmogenicity Testing"],"prefix":"10.1007","volume":"19","author":[{"given":"A. D.","family":"Podgurskaya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V. A.","family":"Tsvelaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. M.","family":"Slotvitsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. V.","family":"Dementyeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. R.","family":"Valetdinova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9258-436X","authenticated-orcid":false,"given":"K. I.","family":"Agladze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,6,5]]},"reference":[{"issue":"3","key":"9532_CR1","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/J.VASCN.2014.09.005","volume":"70","author":"JK Gibson","year":"2014","unstructured":"Gibson, J. K., Yue, Y., Bronson, J., Palmer, C., & Numann, R. (2014). Human stem cell-derived cardiomyocytes detect drug-mediated changes in action potentials and ion currents. Journal of Pharmacological and Toxicological Methods,\n                           70(3), 255\u2013267. \n                    https:\/\/doi.org\/10.1016\/J.VASCN.2014.09.005\n                    \n                  .","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"issue":"2","key":"9532_CR2","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1093\/toxsci\/kft205","volume":"136","author":"L Guo","year":"2013","unstructured":"Guo, L., Coyle, L., Abrams, R. M. C., Kemper, R., Chiao, E. T., & Kolaja, K. L. (2013). Refining the human iPSC-cardiomyocyte arrhythmic risk assessment model. Toxicological Sciences,\n                           136(2), 581\u2013594. \n                    https:\/\/doi.org\/10.1093\/toxsci\/kft205\n                    \n                  .","journal-title":"Toxicological Sciences"},{"issue":"11","key":"9532_CR3","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1056\/NEJMoa040582","volume":"351","author":"WA Ray","year":"2004","unstructured":"Ray, W. A., Murray, K. T., Meredith, S., Narasimhulu, S. S., Hall, K., & Stein, C. M. (2004). Oral erythromycin and the risk of sudden death from cardiac causes. New England Journal of Medicine,\n                           351(11), 1089\u20131096. \n                    https:\/\/doi.org\/10.1056\/NEJMoa040582\n                    \n                  .","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"9532_CR4","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1161\/circep.109.862649","volume":"2","author":"Hideki Itoh","year":"2009","unstructured":"Itoh, H., Sakaguchi, T., Ding, W.-G., Watanabe, E., Watanabe, I., Nishio, Y., \u2026 Horie, M. (2009). Latent Genetic Backgrounds and Molecular Pathogenesis in Drug-Induced Long-QT Syndrome. Circulation: Arrhythmia and Electrophysiology, 2(5), 511\u2013523. \n                    https:\/\/doi.org\/10.1161\/circep.109.862649","journal-title":"Circulation: Arrhythmia and Electrophysiology"},{"issue":"2","key":"9532_CR5","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/J.BBRC.2006.01.008","volume":"341","author":"RS Duncan","year":"2006","unstructured":"Duncan, R. S., Ridley, J. M., Dempsey, C. E., Leishman, D. J., Leaney, J. L., Hancox, J. C., et al. (2006). Erythromycin block of the HERG K\u2009+\u2009channel: Accessibility to F656 and Y652. Biochemical and Biophysical Research Communications,\n                           341(2), 500\u2013506. \n                    https:\/\/doi.org\/10.1016\/J.BBRC.2006.01.008\n                    \n                  .","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"7","key":"9532_CR6","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1016\/S0735-1097(96)00377-4","volume":"28","author":"C Antzelevitch","year":"1996","unstructured":"Antzelevitch, C., Sun, Z.-Q., Zhang, Z.-Q., & Yan, G.-X. (1996). Cellular and ionic mechanisms underlying erythromycin-induced long QT intervals and torsade de pointes. Journal of the American College of Cardiology,\n                           28(7), 1836\u20131848. \n                    https:\/\/doi.org\/10.1016\/S0735-1097(96)00377-4\n                    \n                  .","journal-title":"Journal of the American College of Cardiology"},{"issue":"4","key":"9532_CR7","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1517\/14656566.9.4.537","volume":"9","author":"JP Smits","year":"2008","unstructured":"Smits, J. P., Blom, M. T., Wilde, A. A., & Tan, H. L. (2008). Cardiac sodium channels and inherited electrophysiologic disorders: A pharmacogenetic overview. Expert Opinion on Pharmacotherapy,\n                           9(4), 537\u2013549. \n                    https:\/\/doi.org\/10.1517\/14656566.9.4.537\n                    \n                  .","journal-title":"Expert Opinion on Pharmacotherapy"},{"key":"9532_CR8","doi-asserted-by":"publisher","unstructured":"Lazzerini, P. E., Yue, Y., Srivastava, U., Fabris, F., Capecchi, P. L., Bertolozzi, I., \u2026 Boutjdir, M. (2016). Arrhythmogenicity of Anti-Ro\/SSA Antibodies in Patients With Torsades de Pointes. Circulation: Arrhythmia and Electrophysiology, 9(4), e003419. \n                    https:\/\/doi.org\/10.1161\/circep.115.003419","DOI":"10.1161\/circep.115.003419"},{"key":"9532_CR9","unstructured":"Schulz, M., & Schmoldt, A. (2003). Therapeutic and toxic blood concentrations of more than 800 drugs and other xenobiotics. Die Pharmazie, 58(7), 447\u201374. Retrieved from \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12889529"},{"issue":"1","key":"9532_CR10","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s40064-016-1889-y","volume":"5","author":"J Kuusela","year":"2016","unstructured":"Kuusela, J., Kujala, V. J., Kiviaho, A., Ojala, M., Swan, H., Kontula, K., et al. (2016). Effects of cardioactive drugs on human induced pluripotent stem cell derived long QT syndrome cardiomyocytes. SpringerPlus,\n                           5(1), 234. \n                    https:\/\/doi.org\/10.1186\/s40064-016-1889-y\n                    \n                  .","journal-title":"SpringerPlus"},{"issue":"1\/2","key":"9532_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1023\/A:1027309703313","volume":"254","author":"SJC Stanat","year":"2003","unstructured":"Stanat, S. J. C., Carlton, C. G., Crumb, W. J., Jr., Agrawal, K. C., & Clarkson, C. W. (2003). Characterization of the inhibitory effects of erythromycin and clarithromycin on the HERG potassium channel. Molecular and Cellular Biochemistry,\n                           254(1\/2), 1\u20137. \n                    https:\/\/doi.org\/10.1023\/A:1027309703313\n                    \n                  .","journal-title":"Molecular and Cellular Biochemistry"},{"issue":"8","key":"9532_CR12","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/J.HRTHM.2005.04.029","volume":"2","author":"J Guo","year":"2005","unstructured":"Guo, J., Zhan, S., Lees-Miller, J. P., Teng, G., & Duff, H. J. (2005). Exaggerated block of hERG (KCNH2) and prolongation of action potential duration by erythromycin at temperatures between 37\u00b0C and 42\u00b0C. Heart Rhythm,\n                           2(8), 860\u2013866. \n                    https:\/\/doi.org\/10.1016\/J.HRTHM.2005.04.029\n                    \n                  .","journal-title":"Heart Rhythm"},{"issue":"15","key":"9532_CR13","doi-asserted-by":"publisher","first-page":"4950","DOI":"10.1039\/C7NR00001D","volume":"9","author":"Y Liu","year":"2017","unstructured":"Liu, Y., Xia, T., Wei, J., Liu, Q., & Li, X. (2017). Micropatterned co-culture of cardiac myocytes on fibrous scaffolds for predictive screening of drug cardiotoxicities. Nanoscale,\n                           9(15), 4950\u20134962. \n                    https:\/\/doi.org\/10.1039\/C7NR00001D\n                    \n                  .","journal-title":"Nanoscale"},{"key":"9532_CR14","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.vascn.2016.12.003","volume":"84","author":"Hiroyuki Ando","year":"2017","unstructured":"Ando, H., Yoshinaga, T., Yamamoto, W., Asakura, K., Uda, T., Taniguchi, T., \u2026 Sekino, Y. (2017). A new paradigm for drug-induced torsadogenic risk assessment using human iPS cell-derived cardiomyocytes. Journal of Pharmacological and Toxicological Methods, 84, 111\u2013127. \n                    https:\/\/doi.org\/10.1016\/j.vascn.2016.12.003","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"issue":"6","key":"9532_CR15","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1016\/j.stemcr.2018.04.006","volume":"10","author":"Naim Shaheen","year":"2018","unstructured":"Shaheen, N., Shiti, A., Huber, I., Shinnawi, R., Arbel, G., Gepstein, A., \u2026 Gepstein, L. (2018). Human induced pluripotent stem cell-derived cardiac cell sheets expressing genetically encoded voltage indicator for pharmacological and arrhythmia studies. Stem Cell Reports, 10(6), 1879\u20131894. \n                    https:\/\/doi.org\/10.1016\/j.stemcr.2018.04.006","journal-title":"Stem Cell Reports"},{"issue":"6","key":"9532_CR16","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1089\/scd.2010.0249","volume":"20","author":"Sergey P. Medvedev","year":"2011","unstructured":"Medvedev, S. P., Grigor\u2019eva, E. V., Shevchenko, A. I., Malakhova, A. A., Dementyeva, E. V., Shilov, A. A., \u2026 Zakian, S. M. (2011). Human Induced Pluripotent Stem Cells Derived from Fetal Neural Stem Cells Successfully Undergo Directed Differentiation into Cartilage. Stem Cells and Development, 20(6), 1099\u20131112. \n                    https:\/\/doi.org\/10.1089\/scd.2010.0249","journal-title":"Stem Cells and Development"},{"issue":"8","key":"9532_CR17","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/nmeth.2999","volume":"11","author":"Paul W Burridge","year":"2014","unstructured":"Burridge, P. W., Matsa, E., Shukla, P., Lin, Z. C., Churko, J. M., Ebert, A. D., \u2026 Wu, J. C. (2014). Chemically defined generation of human cardiomyocytes. Nature Methods, 11(8), 855\u2013860. \n                    https:\/\/doi.org\/10.1038\/nmeth.2999","journal-title":"Nature Methods"},{"issue":"1","key":"9532_CR18","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/J.PHARMTHERA.2012.01.001","volume":"134","author":"A Astashkina","year":"2012","unstructured":"Astashkina, A., Mann, B., & Grainger, D. W. (2012). A critical evaluation of in vitro cell culture models for high-throughput drug screening and toxicity. Pharmacology & Therapeutics,\n                           134(1), 82\u2013106. \n                    https:\/\/doi.org\/10.1016\/J.PHARMTHERA.2012.01.001\n                    \n                  .","journal-title":"Pharmacology & Therapeutics"},{"issue":"3","key":"9532_CR19","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nrd3373","volume":"10","author":"O Kepp","year":"2011","unstructured":"Kepp, O., Galluzzi, L., Lipinski, M., Yuan, J., & Kroemer, G. (2011). Cell death assays for drug discovery. Nature Reviews Drug Discovery,\n                           10(3), 221\u2013237. \n                    https:\/\/doi.org\/10.1038\/nrd3373\n                    \n                  .","journal-title":"Nature Reviews Drug Discovery"},{"issue":"1","key":"9532_CR20","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/J.TOXLET.2013.02.020","volume":"219","author":"CW Scott","year":"2013","unstructured":"Scott, C. W., Peters, M. F., & Dragan, Y. P. (2013). Human induced pluripotent stem cells and their use in drug discovery for toxicity testing. Toxicology Letters,\n                           219(1), 49\u201358. \n                    https:\/\/doi.org\/10.1016\/J.TOXLET.2013.02.020\n                    \n                  .","journal-title":"Toxicology Letters"},{"issue":"12","key":"9532_CR21","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/nrd3577","volume":"10","author":"M Grskovic","year":"2011","unstructured":"Grskovic, M., Javaherian, A., Strulovici, B., & Daley, G. Q. (2011). Induced pluripotent stem cells\u2014opportunities for disease modelling and drug discovery. Nature Reviews Drug Discovery,\n                           10(12), 915. \n                    https:\/\/doi.org\/10.1038\/nrd3577\n                    \n                  .","journal-title":"Nature Reviews Drug Discovery"},{"issue":"3","key":"9532_CR22","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/nrm.2015.27","volume":"17","author":"Y Avior","year":"2016","unstructured":"Avior, Y., Sagi, I., & Benvenisty, N. (2016). Pluripotent stem cells in disease modelling and drug discovery. Nature Reviews Molecular Cell Biology,\n                           17(3), 170\u2013182. \n                    https:\/\/doi.org\/10.1038\/nrm.2015.27\n                    \n                  .","journal-title":"Nature Reviews Molecular Cell Biology"},{"issue":"7337","key":"9532_CR23","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/nature09747","volume":"471","author":"Ilanit Itzhaki","year":"2011","unstructured":"Itzhaki, I., Maizels, L., Huber, I., Zwi-Dantsis, L., Caspi, O., Winterstern, A., \u2026 Gepstein, L. (2011). Modelling the long QT syndrome with induced pluripotent stem cells. Nature, 471(7337), 225\u2013229. \n                    https:\/\/doi.org\/10.1038\/nature09747","journal-title":"Nature"},{"issue":"2","key":"9532_CR24","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/J.SCR.2009.11.004","volume":"4","author":"SR Braam","year":"2010","unstructured":"Braam, S. R., Tertoolen, L., van de Stolpe, A., Meyer, T., Passier, R., & Mummery, C. L. (2010). Prediction of drug-induced cardiotoxicity using human embryonic stem cell-derived cardiomyocytes. Stem Cell Research,\n                           4(2), 107\u2013116. \n                    https:\/\/doi.org\/10.1016\/J.SCR.2009.11.004\n                    \n                  .","journal-title":"Stem Cell Research"},{"issue":"4","key":"9532_CR25","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.bbrc.2009.05.073","volume":"385","author":"Tomofumi Tanaka","year":"2009","unstructured":"Tanaka, T., Tohyama, S., Murata, M., Nomura, F., Kaneko, T., Chen, H., \u2026 Fukuda, K. (2009). In vitro pharmacologic testing using human induced pluripotent stem cell-derived cardiomyocytes. Biochemical and Biophysical Research Communications, 385(4), 497\u2013502. \n                    https:\/\/doi.org\/10.1016\/j.bbrc.2009.05.073","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"16","key":"9532_CR26","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1161\/CIRCULATIONAHA.113.001883","volume":"127","author":"Ping Liang","year":"2013","unstructured":"Liang, P., Lan, F., Lee, A. S., Gong, T., Sanchez-Freire, V., Wang, Y., \u2026 Wu, J. C. (2013). Drug screening using a library of human induced pluripotent stem cell\u2013derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity. Circulation, 127(16), 1677\u20131691. \n                    https:\/\/doi.org\/10.1161\/circulationaha.113.001883","journal-title":"Circulation"},{"issue":"1","key":"9532_CR27","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1093\/toxsci\/kfy274","volume":"168","author":"M Slotvitsky","year":"2019","unstructured":"Slotvitsky, M., Tsvelaya, V., Frolova, S., Dementyeva, E., & Agladze, K. (2019). Arrhythmogenicity test based on a human-induced pluripotent stem cell (iPSC)-derived cardiomyocyte layer. Toxicological Sciences,\n                           168(1), 70\u201377. \n                    https:\/\/doi.org\/10.1093\/toxsci\/kfy274\n                    \n                  .","journal-title":"Toxicological Sciences"},{"key":"9532_CR28","doi-asserted-by":"crossref","unstructured":"Pond, A. L., Scheve, B. K., Benedict, A. T., Petrecca, K., Van Wagoner, D. R., Shrier, A., & Nerbonne, J. M. (2000). Expression of distinct ERG proteins in rat, mouse, and human heart. Relation to functional I(Kr) channels. The Journal of biological chemistry, 275(8), 5997\u20136006. Retrieved from \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10681594","DOI":"10.1074\/jbc.275.8.5997"},{"issue":"6","key":"9532_CR29","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1016\/S0006-3495(01)75943-7","volume":"81","author":"SV Pandit","year":"2001","unstructured":"Pandit, S. V., Clark, R. B., Giles, W. R., & Demir, S. S. (2001). A mathematical model of action potential heterogeneity in adult rat left ventricular myocytes. Biophysical Journal,\n                           81(6), 3029\u20133051. \n                    https:\/\/doi.org\/10.1016\/S0006-3495(01)75943-7\n                    \n                  .","journal-title":"Biophysical Journal"}],"container-title":["Cardiovascular Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-019-09532-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12012-019-09532-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-019-09532-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T19:23:55Z","timestamp":1591212235000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12012-019-09532-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,5]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["9532"],"URL":"https:\/\/doi.org\/10.1007\/s12012-019-09532-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/574012","asserted-by":"object"}]},"ISSN":["1530-7905","1559-0259"],"issn-type":[{"value":"1530-7905","type":"print"},{"value":"1559-0259","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,5]]},"assertion":[{"value":"5 June 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. All applicable international, national, and\/or institutional guidelines for the care and use of animals were followed.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}